Abstract
IT is desirable to prolong current forms of regional cancer infusion therapy by the use of a mechanism permitting, on an ambulatory, outpatient basis, parenteral administration of fluid containing antimetabolite drugs. A device has been developed and is currently in use on the cancer chemotherapy service at the Lahey Clinic to infuse small volumes of drug (3 to 5 ml. in twenty-four hours) accurately for periods of weeks or even months. The mechanism is also proving valuable in the animal laboratory since it permits the continuous parenteral infusion of drugs into unrestrained large animals (dogs).The miniaturized self-contained infusion assembly . . .
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
